BOWIE, Md., April 25, 2018 -- Inovalon (Nasdaq:INOV), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based models across the healthcare ecosystem, today announced that it will hold a conference call for investors on Tuesday, May 8, 2018, at 5:00 p.m. Eastern Time. During the conference call, management will review highlights from the company’s first quarter financial results, which will be announced via press release after the close of market trading on Tuesday, May 8, 2018.
The conference call can be accessed by dialing (855) 783-2604, conference ID 9884025; international callers should dial (631) 485-4882 using the same ID. The call will be available for replay on Inovalon’s website at www.inovalon.com.
About Inovalon
Inovalon is a leading technology company providing cloud-based platforms empowering a data-driven transformation from volume-based to value-based models throughout the healthcare industry. Through the Inovalon ONE™ Platform, Inovalon brings to the marketplace a national-scale capability to interconnect with the healthcare ecosystem, aggregate and analyze data in petabyte volumes to arrive at sophisticated insights in real-time, drive impact wherever it is analytically identified best to intervene, and intuitively visualize data and information to inform business strategy and execution. Leveraging its platform, unparalleled proprietary data sets, and industry-leading subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon's unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action®.” Providing technology that supports a client base approaching 500 healthcare organizations, Inovalon's platforms are informed by data pertaining to more than 932,000 physicians, more than 455,000 clinical facilities, and 240 million Americans. For more information, visit www.inovalon.com.
Contacts:
Kim Collins
Phone: 301-809-4000 x1473
[email protected]
George Price (Investors)
Phone: 301-809-4000 x1190
[email protected]


Trump Administration Plans New Drug Pricing Deals With Biotech Firms
Google Expands Gemini Enterprise With AI Tools for Legal Sector
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
SK Hynix Shares Fall as Workers Reject Wage Deal
SEC Probes Banks Over Situational Awareness Hedge Fund Collapse
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny
Woodside Drops $5 Billion Clean Energy Plan as Profit Rises 7%
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition
Luxshare Shares Rise as First-Half Profit Jumps 18%
Bathla Group Hires Administrators as Australia Housing Slump Deepens
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14%
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 



